<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01193894</url>
  </required_header>
  <id_info>
    <org_study_id>CUPE2</org_study_id>
    <nct_id>NCT01193894</nct_id>
  </id_info>
  <brief_title>Trial on Profermin and Fresubin in Ulcerative Colitis</brief_title>
  <acronym>CUPE2</acronym>
  <official_title>A Randomized Trial on Profermin and Fresubin for Dietetic Treatment of Active Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nordisk Rebalance A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nordisk Rebalance A/S</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to investigate the effect of Profermin versus Fresubin in the dietetic
      treatment of active ulcerative colitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Development in Simple Clinical Colitis Activity Index (SCCAI) score</measure>
    <time_frame>8 and 16 weeks</time_frame>
    <description>Clinical significant difference (&gt;1.5) in course of SCCAI score between the two intervention groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in SCCAI score</measure>
    <time_frame>8 and 16 weeks</time_frame>
    <description>Proportion of patients with a reduction in SCCAI above 1.5, 3.0 and 4.5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical remission</measure>
    <time_frame>8 and 16 weeks</time_frame>
    <description>Proportion of patients in clinical remission (SCCAI=&lt;2.5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety - Number of Participants with Adverse Events as a Measure of Safety and Tolerability</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Profermin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresubin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Profermin</intervention_name>
    <description>Medical Food (food for special medical purposes)</description>
    <arm_group_label>Profermin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fresubin</intervention_name>
    <description>Medical food (food for special medical purposes)</description>
    <arm_group_label>Fresubin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Active ulcerative colitis (SCCAI =&gt;5 and &lt;=11)

          -  Access to Internet

        Exclusion Criteria:

          -  Stoma or intestinal resections

          -  Recent changes in UC medication

          -  Treatment with antibiotics

          -  Diabetes

          -  Celiac disease

          -  Lactose malabsorption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Israelsen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Nordisk Rebalance A/S</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aleksander Krag, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Flemming Bendtsen, MD, DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Noreba</name>
      <address>
        <city>Allerod</city>
        <state>Capital region</state>
        <zip>3450</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2010</study_first_submitted>
  <study_first_submitted_qc>September 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2010</study_first_posted>
  <last_update_submitted>December 16, 2013</last_update_submitted>
  <last_update_submitted_qc>December 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IBD</keyword>
  <keyword>UC</keyword>
  <keyword>Profermin</keyword>
  <keyword>Fresubin</keyword>
  <keyword>Probiotics</keyword>
  <keyword>Dietetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

